Showing results (181-190 of 296) with videos related to
Sort By:
Pageof 30
European Journal of Haematology|October 7, 2011
Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myelomaLiang-Tsai Hsiao, Ching-Fen Yang, Sheng-Hsiang Yang, et al.Journal of Pharmaceutical and Biomedical Analysis|April 5, 2016
Development of a robust reporter-based assay for the bioactivity determination of anti-VEGF therapeutic antibodiesLan Wang, Gang-Ling Xu, Kai Gao, et al.Journal of Clinical Medicine|August 30, 2018
SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen TreatmentYu-Hsiang Huang, Pei-Yi Chu, Ji-Lin Chen, et al.International Journal of Oncology|January 23, 2016
Cytotoxic mechanism of PLK1 inhibitor GSK461364 against osteosarcoma: Mitotic arrest, apoptosis, cellular senescence, and synergistic effect with paclitaxelYi-Sheng Chou, Chueh-Chuan Yen, Wei-Ming Chen, et al.Journal of Molecular Medicine (Berlin, Germany)|May 25, 2026
MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBCLing-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, et al.World Journal of Oncology|January 24, 2025
Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical OutcomesYi-Fang Tsai, Jiun-I Lai, Chun-Yu Liu, et al.International Journal of Molecular Sciences|January 27, 2024
Genomic Alterations of Tumors in HER2-Low Breast CancersYi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, et al.Hepato-Gastroenterology|April 28, 2015
External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinomaSan-Chi Chen, Ming-Huang Chen, Chung-Pin Li, et al.Clinical Epigenetics|February 26, 2025
HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancerTing-I Lin, Yi-Ru Tseng, Min-Jyun Dong, et al.Histopathology|December 6, 2018
HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancerYi-Fang Tsai, Ling-Ming Tseng, Pei-Ju Lien, et al.Pageof 30